Microbot Medical Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Microbot Medical stock has a consensus rating of "Strong Buy" and an average price target of $7.00. The average 1-year stock price forecast is 276.34% higher than the current stock price, while the lowest is $4.00 (+115.05%) and the highest is $12 (+545.16%).

Price Target: $7.00 (+276.34%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.00	$7.00	$5.00	$12
Change	+115.05%	+276.34%	+168.82%	+545.16%

Analyst Ratings

The average analyst rating for Microbot Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	2	3	3	3	2	3
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	3	3	3	2	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Lucid Capital No rating	Lucid Capital	Buy Initiates $4	Buy	Initiates	$4	+115.05%	Jun 3, 2026
Ram Selvaraju H.C. Wainwright	H.C. Wainwright	Buy Reiterates $12	Buy	Reiterates	$12	+545.16%	Apr 14, 2026
Kyle Bauser Roth MKM	Roth MKM	Buy Reiterates $5.5	Buy	Reiterates	$5.5	+195.70%	Apr 13, 2026
Anderson Schock B. Riley Securities	B. Riley Securities	Buy Initiates $5	Buy	Initiates	$5	+168.82%	Feb 10, 2026

Financial Forecast

Revenue This Year

3.45M

Revenue Next Year

10.60M

from 3.45M

207.25%

from 3.45M

EPS This Year

-0.30

from -0.29

EPS Next Year

-0.32

from -0.30

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	3.45M
Operating Income	-11.36M	-13.28M	-9.86M	-11.63M	-14.74M	-22.04M
Net Income	-11.31M	-13.17M	-10.74M	-11.44M	-13.14M	-20.45M
EPS	-	-	-	-	-0.29	-0.30
Free Cash Flow	-4.94M	-6.67M	-3.81M	-5.87M	-8.32M	-24.00M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	3.5M
Avg	3.5M
Low	3.4M

Revenue Growth

Revenue Growth	2027	2028
High	218.8%
Avg	207.2%
Low	195.7%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.30
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-